Prior to the discussion on Mesothelioma treatment options, one has to understand what it is all about. Mesothelioma is a kind of cancer that occurs due to excessive exposure to asbestos. Any kind of cancer is not curable once it reaches the final stages; so is Mesothelioma.

Pleural Mesothelioma has three stages whereas Peritoneal Mesothelioma has no stages. If a patient suffering from the former kind of cancer and is in stage I or stage II, the treatment options include traditional and conventional treatments.

Under traditional treatment, the patient is subjected to surgery, radiation, and chemotherapy. Aggressive treatment cannot be given to patients for whom age plays a vital role in the weakening of immune system. There are other diseases that also contribute to the weak immune system. For such people, there are alternate treatments. However, not all the treatment methods have received approval.

Tri-modality therapy is a combination of surgery, radiation as well as chemotherapy. The other Mesothelioma treatment options include Immunotherapy, Gamma therapy, Photodynamic therapy. IMRT or “Intensity Modulated Radiation Therapy” is another treatment where radiation of predetermined dosage is delivered to the affected regions.
Research is still going on to find the best method to combat cancer that has never had a cure as of date.

Around 51,456 women who were suffering from heavy bleeding were investigated. Hysterectomy was found in 4 out of 10 women on an average. Surprisingly, this varied with region and the range is in between 25 and 54 percent.

GPs are being seen is one out of every 20 women in England due to this heavy bleeding. There are a variety of effective treatments and the study reveals that it is important to provide evident information before going for irreversible treatments like hysterectomy.

The vice president of RCOG says that there is a treatment that is more conservative but this research highlighted the role that is important in the surgery. Both the risks as well as benefits associated with the surgery must be explained in details to the women who are suffering from bleeding before actually going for the treatment.

This informative research was published in the latest edition of BJOG.